Vista Pharmaceuticals Ltd — Board Meeting, 13-08-2025: Board Meeting

Vista Pharmaceuticals' board approved the quarter's financial results: Revenue from operations dropped to Rs. 1.52 Cr from Rs. 1.80 Cr year-over-year, with net loss widening to Rs. 1.29 Cr from Rs. 0.86 Cr. The board put forward the re-appointment of Directors Mr. Umakanth Katta and Mr. Divakar Reddy. For a second three-year term, Mr. Murali Meraga (MD, 9.00 Cr shares), Mr. Pavan Sathvik Gilaka (WTD, 7.76 Cr shares), and Mr. Dhananjaya Alli (WTD, 2.89 Cr shares) were also proposed for re-appointment, pending shareholder approval at the September 30th AGM.